Cannabidiol shows promise in treating cognitive disorders

Research reviews the therapeutic potential of cannabidiol (CBD) in treating cognitive impairments, highlighting positive effects in some trials while emphasizing the need for more comprehensive studies.

New AI-nanopore platform could revolutionize COVID-19 testing

A rapid, accurate way of testing for COVID-19 infection would be a big step in overcoming the virus’ hold over our society.

October 26, 2023

Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2023 | Psychedelic Invest

CAMBRIDGE, Mass., March 26, 2024–(BUSINESS WIRE)–Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics

March 26, 2024

Centessa’s public offering; Vivoryon ends Ph2 Alzheimer’s trial

Plus, news about EXO Biologics: Centessa prices public offering: The startup aims to raise $93.5 million, or up to $107.6 million if all options are

April 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.